Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...
The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better Approaches to Lifestyle and Nutrition for ...
Thousands of New Jerseyans who lost federal subsidies that helped them buy health insurance have dropped their coverage, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results